ALC:NYSE
Alcon AG
၇၃.၇၂ US$
arrow_upward
+၀.၀၈%(+၀.၀၆၀) 1D
နို ၁၇, GMT-၅ ၀၉:၄၉:၃၂ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
၇၃.၄၀ US$
High
၇၃.၉၄ US$
Low
၇၃.၃၆ US$
Mkt. cap
ဋေ ၃.၁၀ ထ
Avg. vol.
၂.၁၅ သန်း
Volume
၅.၃၆ သောင်း
52-wk high
၈၇.၆၄ US$
52-wk low
၆၁.၈၄ US$
Beta
၀.၈၇
Shares outstanding
၄၈.၃၄ ကုဋေ
No. of employees
၂ သောင်း
Open
၇၃.၄၀ US$
High
၇၃.၉၄ US$
Low
၇၃.၃၆ US$
Mkt. cap
ဋေ ၃.၁၀ ထ
Avg. vol.
၂.၁၅ သန်း
Volume
၅.၃၆ သောင်း
52-wk high
၈၇.၆၄ US$
52-wk low
၆၁.၈၄ US$
Beta
၀.၈၇
Shares outstanding
၄၈.၃၄ ကုဋေ
No. of employees
၂ သောင်း
News stories
From web sources and news partners
ChartMill
·
ပြီးခဲ့သည့် ၁ နာရီ
S&P 500 Premarket Movers on Nov. 17: Gainers and Losers
The Motley Fool
·
ပြီးခဲ့သည့် ၂၃ မိနစ်
Prediction: Dec. 9 Will Mark a Turning Point for the S&P 500
FOREX.com
·
ပြီးခဲ့သည့် ၁ နာရီ
S&P 500 forecast: Why US stocks have largely defied gravity and what could trigger a correction
Traders Union
·
ပြီးခဲ့သည့် ၄၀ မိနစ်
S&P 500 could deliver 18% total return by 2027, Goldman Sachs projects
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees၂.၅ သောင်း
Founded၁၉၄၅
Headquartersဂျနီဗာမြို့, Geneva, ဆွစ်ဇာလန်
SectorHealth Care
Industry-
Websitealcon.com